Workflow
Forian(FORA) - 2025 Q1 - Quarterly Results
FORAForian(FORA)2025-05-14 20:29

Revenue Performance - Revenue for Q1 2025 was 7.1million,a457.1 million, a 45% increase from 4.9 million in Q1 2024[5] - Revenue for the period ended March 31, 2025, was 7,056,116,comparedto7,056,116, compared to 4,877,378 for the same period in 2024, representing a year-over-year increase of approximately 44.7%[26] - For the full year 2025, revenue is expected to be in the range of 28to28 to 30 million[11] Net Loss and Adjusted EBITDA - Net loss for the quarter was 1.1million,or1.1 million, or 0.04 per share, compared to a net loss of 1.2million,or1.2 million, or 0.04 per share, in the prior year[5] - Net loss for the period ended March 31, 2025, was (1,125,862),animprovementfromanetlossof(1,125,862), an improvement from a net loss of (1,212,615) in the prior year, indicating a reduction in losses of about 7.1%[26] - Adjusted EBITDA for the quarter was (0.1)million,adeclineof149(0.1) million, a decline of 149% from 0.1 million in the prior year[5] - Adjusted EBITDA for the full year 2025 is expected to be in the range of (1.0)to1.0) to 1.0 million[11] - Adjusted EBITDA for the period ended March 31, 2025, was (50,778),comparedto(50,778), compared to 104,417 in the same period of 2024, reflecting a decline in operational performance[26] Cash and Liquidity - Cash, cash equivalents, and marketable securities totaled 35.7millionasofMarch31,2025[5]−Cashandcashequivalentsattheendoftheperiodwere35.7 million as of March 31, 2025[5] - Cash and cash equivalents at the end of the period were 5,704,671, up from 1,029,128attheendofthepreviousyear,markingasignificantincreaseinliquidity[17]−Netcashprovidedbyoperatingactivitieswas1,029,128 at the end of the previous year, marking a significant increase in liquidity[17] - Net cash provided by operating activities was 448,180 for the period, a substantial recovery from (2,208,070)intheprioryear[17]−Cashusedinfinancingactivitieswas(2,208,070) in the prior year[17] - Cash used in financing activities was (172,295) for the period, a decrease from (1,031,363)intheprioryear,indicatingimprovedcashmanagement[17]AssetsandLiabilities−Totalcurrentassetsincreasedto(1,031,363) in the prior year, indicating improved cash management[17] Assets and Liabilities - Total current assets increased to 46.4 million from 44.5millionasofDecember31,2024[13]−Totalliabilitiesincreasedto44.5 million as of December 31, 2024[13] - Total liabilities increased to 18.6 million from 17.1millionasofDecember31,2024[13]OperationalImprovements−Thecompanyachievedcontinuedgrowthfrompharmaceuticalandbiotechcompanies,reflectingincreasedadoptionofitsdatasolutions[5]−ThecompanyintegratedKyberDataScience′splatform,enhancingitspredictiveanalyticsandfinancialservicescapabilities[5]−Thecompanyincurredstock−basedcompensationexpenseof17.1 million as of December 31, 2024[13] Operational Improvements - The company achieved continued growth from pharmaceutical and biotech companies, reflecting increased adoption of its data solutions[5] - The company integrated Kyber Data Science's platform, enhancing its predictive analytics and financial services capabilities[5] - The company incurred stock-based compensation expense of 1,292,786 for the period, down from 1,658,915inthepreviousyear,indicatingareductionofapproximately22.11,658,915 in the previous year, indicating a reduction of approximately 22.1%[26] - The company reported accrued interest on convertible notes of 51,344 for the period, significantly lower than 197,630inthepreviousyear,reflectingadecreaseofapproximately74.0197,630 in the previous year, reflecting a decrease of approximately 74.0%[17] - The company’s accounts receivable decreased by (1,400,838) compared to (1,694,851)inthepreviousyear,indicatingimprovedcollectionefforts[17]MarketableSecurities−Thecompanyreportedagainonsaleofmarketablesecuritiesamountingto(1,694,851) in the previous year, indicating improved collection efforts[17] Marketable Securities - The company reported a gain on sale of marketable securities amounting to 30,546,000, compared to $45,359,108 in the previous year, showing a decrease of about 32.6%[17]